21EGP
- Active ingredient
- gliquidone
- Strength
- 30 mg
- Form
- tablet
- Manufacturer
- mina pharm > menarini
- Route
- oral.solid
Uses
Indicated for the treatment of type 2 diabetes mellitus when diet and lifestyle measures alone are insufficient.
Do not use if
Type 1 diabetes, diabetic ketoacidosis, or hypersensitivity to sulfonylureas.
Side effects
May cause hypoglycemia, weight gain, nausea, or skin reactions.
Warnings
Monitor blood glucose regularly and be alert for signs of hypoglycemia.
How it works
A sulfonylurea that stimulates insulin secretion from pancreatic beta cells.
Storage
Store at room temperature protected from moisture.